Fairvalue-Calculator Fairvalue-Calculator
EN DE

Nephros, Inc (NEPH) Fair Value & Analysis

Healthcare · US · Market cap $34.2M

Price$3.30
Fair Value$2.30
Upside-30.3%
Quality95/100
Evidence: High Range $1.81 – $2.77

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Nephros, Inc (NEPH) currently trades at $3.30, while our model-based Fair Value estimate is $2.30 — implying the stock looks roughly 30.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -61% EssilorLuxottica Société anonyme (ESLOF) -44% HOYA Corporation (HOCPY) -43% Medline Inc (MDLN) -5% Becton, Dickinson and Company (BDX) -16% Alcon Inc (ALC) -44%

Frequently asked questions

Is Nephros, Inc (NEPH) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $2.30 versus a price of $3.30 — about −30% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NEPH?
Our 21-model fair value for Nephros, Inc is $2.30 (as of Jun 24, 2026), built from audited fundamentals. The current price is $3.30.
What is the quality score of NEPH?
Nephros, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.